The recent webinar "The Human Microbiome and COVID-19: Investigating a Potential Connection" offered an exclusive look into a pioneering clinical investigation that wrapped up in August. The research is being led by Dr. Martin J. Blaser, Henry...
FDA has now widened its Covid-19 warning letter net to include pharmacists as well as other health care providers and dietary supplement manufacturers and marketers.
The associations between vitamin D status and COVID-19 risk continue to strengthen, with new data from Quest Diagnostics and Boston University indicating that people with deficiency in the sunshine vitamin may have a significantly higher positivity rate...
A ‘Regulatory Gap’ exists within the US dietary supplements industry, and recent talk of modernizing the regulations are ways to close that gap, FDA’s Steven Tave said yesterday
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, recently did an Instagram Live interview with the actress Jennifer Garner where he discussed immune health and supplementation.
The US Food and Drug Administration rejected mid-August a New Dietary Ingredient notification from Phoenix Biotechnology Inc for oleandrin, a constituent of oleander touted as a COVID-19 cure.
Scientists at the University of Chicago are calling for clinical trials to investigate if vitamin D may reduce COVID-19 incidence after their retrospective study found a link between deficiency of the sunshine vitamin and the likelihood of becoming infected...
Consumer usage of probiotic supplements in the US increased by 66% in May, compared to six months earlier, with daily usage also increasing, according to a new survey from DuPont Nutrition & Biosciences.
Older adults who take a daily multivitamin and mineral supplement experience sickness for shorter periods and with less severe symptoms, according to a 12-week study.
Forty-three percent of dietary supplement users have changed their regimens during the COVID-19 pandemic to boost overall usage, says a new survey by IPSOS commissioned by CRN that hints at lasting changes to their approach to supplementation.
The pandemic crisis has boosted the sales of ashwagandha, but suppliers agree that even before this year’s unusual market conditions, interest in the adaptogenic herb had been on the rise.
Sources in the natural products industry were nearly unanimous in condemning the Trump Administration’s apparent new found enthusiasm for a toxic oleander extract as a potential COVID-19 cure.
A new cohort study involving 9940 men and women has added to the mounting research to indicate vitamin D supplementation may reduce the seriousness of COVID-19 infections.
The pandemic has created severe challenges for some retailers, while others have prospered. Natural Grocers fits in the latter category, reporting record earnings for its third quarter of fiscal 2020.
While sales of immunity health products have been strong for most of 2020, consumer interest in other categories is also surging, from sleep and stress management to a resurgence in sports nutrition, says the COO of The Vitamin Shoppe.
